Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data |
Kim, Won Gu
(Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine)
Kim, Tae Yong (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Kim, Tae Hyuk (Department of Internal Medicine, Seoul National University College of Medicine) Jang, Hye Won (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Jo, Young Suk (Department of Internal Medicine, Chungnam National University School of Medicine) Park, Young Joo (Department of Internal Medicine, Seoul National University College of Medicine) Kim, Sun Wook (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Won Bae (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Shong, Minho (Department of Internal Medicine, Chungnam National University School of Medicine) Park, Do Joon (Department of Internal Medicine, Seoul National University College of Medicine) Chung, Jae Hoon (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Shong, Young Kee (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Cho, Bo Youn (Department of Internal Medicine, Chung-Ang University College of Medicine) |
1 | O'Neill CJ, Vaughan L, Learoyd DL, Sidhu SB, Delbridge LW, Sywak MS. Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol 2011;37:181-185. DOI |
2 | American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-1214. DOI ScienceOn |
3 | Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008;36:425-437. DOI ScienceOn |
4 | Sorrenti S, Trimboli P, Catania A, Ulisse S, De Antoni E, D'Armiento M. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hurthle cell neoplasm. Thyroid 2009;19:355-360. DOI ScienceOn |
5 | Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn Cytopathol 2006;34:330-334. DOI ScienceOn |
6 | Lopez-Penabad L, Chiu AC, Hoff AO, et al. Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. Cancer 2003;97:1186-1194. DOI ScienceOn |
7 | Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988;67:501-508. DOI |
8 | Goffredo P, Roman SA, Sosa JA. Hurthle cell carcinoma: a population-level analysis of 3311 patients. Cancer 2013;119:504-511. DOI |
9 | Passler C, Scheuba C, Prager G, et al. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 2004;11:131-139. DOI |
10 | D'Avanzo A, Treseler P, Ituarte PH, et al. Follicular thyroid carcinoma: histology and prognosis. Cancer 2004;100:1123-1129. DOI ScienceOn |
11 | Sugino K, Ito K, Nagahama M, et al. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid 2011;21:751-757. DOI |
12 | Baloch ZW, LiVolsi VA. Our approach to follicular-patterned lesions of the thyroid. J Clin Pathol 2007;60:244-250. |
13 | DeGroot LJ, Kaplan EL, Shukla MS, Salti G, Straus FH. Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 1995;80:2946-2953. |
14 | Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1991;66:11-22. DOI ScienceOn |
15 | Donohue JH, Goldfien SD, Miller TR, Abele JS, Clark OH. Do the prognoses of papillary and follicular thyroid carcinomas differ? Am J Surg 1984;148:168-173. DOI ScienceOn |
16 | Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989;63:908-911. DOI ScienceOn |
17 | Lo CY, Chan WF, Lam KY, Wan KY. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 2005;242:708-715. DOI ScienceOn |
18 | Phitayakorn R, McHenry CR. Follicular and Hurthle cell carcinoma of the thyroid gland. Surg Oncol Clin N Am 2006;15:603-623. DOI ScienceOn |
19 | Ganly I, Ricarte Filho J, Eng S, et al. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. J Clin Endocrinol Metab 2013;98:E962-E972. DOI |
20 | Gosain AK, Clark OH. Hurthle cell neoplasms: malignant potential. Arch Surg 1984;119:515-519. DOI |
21 | Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer 2013;13:184-199. DOI ScienceOn |
22 | Correa P, Chen VW. Endocrine gland cancer. Cancer 1995;75(1 Suppl):338-352. DOI ScienceOn |
23 | Grebe SK, Hay ID. Follicular thyroid cancer. Endocrinol Metab Clin North Am 1995;24:761-801. |
24 | Asari R, Koperek O, Scheuba C, et al. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Ann Surg 2009;249:1023-1031. DOI ScienceOn |